141 related articles for article (PubMed ID: 34996670)
1. Trends of treated hepatitis B, hepatitis C, and tuberculosis infection in long-term hemodialysis patients in Taiwan: A nationwide survey in 2010-2018.
Lee JJ; Chang JM; Yang LJ; Hsu CC; Lin MH; Lin MY
J Formos Med Assoc; 2022 Feb; 121 Suppl 1():S73-S81. PubMed ID: 34996670
[TBL] [Abstract][Full Text] [Related]
2. The role of chronic viral hepatitis on tuberculosis treatment interruption.
Chua AP; Lim LK; Gan SH; Chee CB; Wang YT
Int J Tuberc Lung Dis; 2018 Dec; 22(12):1486-1494. PubMed ID: 30606322
[TBL] [Abstract][Full Text] [Related]
3. Viral hepatitis prevalence in patients with active and latent tuberculosis.
Nooredinvand HA; Connell DW; Asgheddi M; Abdullah M; O'Donoghue M; Campbell L; Wickremasinghe MI; Lalvani A; Kon OM; Khan SA
World J Gastroenterol; 2015 Aug; 21(29):8920-6. PubMed ID: 26269682
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors.
Alashek WA; McIntyre CW; Taal MW
BMC Infect Dis; 2012 Oct; 12():265. PubMed ID: 23082935
[TBL] [Abstract][Full Text] [Related]
5. The prevalence and associated factors of hepatitis B and C virus in hemodialysis patients in Africa: A systematic review and meta-analysis.
Adane T; Getawa S
PLoS One; 2021; 16(6):e0251570. PubMed ID: 34157037
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of hepatitis B, hepatitis C and HIV infection among patients undergoing haemodialysis in Buenos Aires, Argentina.
Pereson MJ; Martínez AP; Isaac K; Laham G; Ridruejo E; Garcia GH; Flichman DM; Di Lello FA
J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33180017
[No Abstract] [Full Text] [Related]
9. Prevention of hepatitis B virus and hepatitis C virus transmission in hemodialysis centers: review of current international recommendations.
Elamin S; Abu-Aisha H
Arab J Nephrol Transplant; 2011 Jan; 4(1):35-47. PubMed ID: 21469594
[TBL] [Abstract][Full Text] [Related]
10. The Hepatitis Viral Status in Patients With Hepatocellular Carcinoma: a Study of 3843 Patients From Taiwan Liver Cancer Network.
Chang IC; Huang SF; Chen PJ; Chen CL; Chen CL; Wu CC; Tsai CC; Lee PH; Chen MF; Lee CM; Yu HC; Lo GH; Yeh CT; Hong CC; Eng HL; Wang J; Tseng HH; Hsiao CH; Wu HI; Yen TC; Liaw YF
Medicine (Baltimore); 2016 Apr; 95(15):e3284. PubMed ID: 27082566
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C and hepatitis B virus infection in hemodialysis patients after nationwide direct antiviral agents therapy-experience of 10 Romanian HD centers.
Marc L; Mihaescu A; Lupusoru R; Schiller O; Bob F; Chisavu L; Bende F; Sirli R; Schiller A
Int Urol Nephrol; 2023 Nov; 55(11):2951-2958. PubMed ID: 37024632
[TBL] [Abstract][Full Text] [Related]
12. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
Miyasaka M
Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B and C virus infection among hemodialysis patients in Yogyakarta, Indonesia: Prevalence and molecular evidence for nosocomial transmission.
Rinonce HT; Yano Y; Utsumi T; Heriyanto DS; Anggorowati N; Widasari DI; Lusida MI; Soetjipto ; Prasanto H; Hotta H; Hayashi Y
J Med Virol; 2013 Aug; 85(8):1348-61. PubMed ID: 23919229
[TBL] [Abstract][Full Text] [Related]
14. Comorbidities in patients with chronic hepatitis C and hepatitis B on hemodialysis.
Hsu PY; Wei YJ; Liang PC; Lee JJ; Niu SW; Huang JC; Hsu CT; Jang TY; Huang CI; Lin YH; Hsieh MY; Hsieh MH; Chen SC; Dai CY; Lin ZY; Chen SC; Huang JF; Chang JM; Yeh ML; Huang CF; Chiu YW; Hwang SJ; Chuang WL; Yu ML
J Gastroenterol Hepatol; 2021 Aug; 36(8):2261-2269. PubMed ID: 33651428
[TBL] [Abstract][Full Text] [Related]
15. Quality control measures for lowering the seroconversion rate of hemodialysis patients with hepatitis B or C virus.
Yuan J; Yang Y; Han F; Zhang P; Du XY; Jiang H; Chen JH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):302-6. PubMed ID: 22672825
[TBL] [Abstract][Full Text] [Related]
16. HBV-DNA in hemodialysis patients infected by HCV.
Arababadi MK; Hassanshahi G; Yousefi H
Saudi J Kidney Dis Transpl; 2009 May; 20(3):398-401. PubMed ID: 19414941
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of hepatitis B and C among tuberculosis patients in Duhok Province, Kurdistan: Are HBsAg and anti-HCV prerequisite screening parameters in tuberculosis control program?
Merza MA; Haji SM; Alsharafani AM; Muhammed SU
Int J Mycobacteriol; 2016 Sep; 5(3):313-317. PubMed ID: 27847016
[TBL] [Abstract][Full Text] [Related]
18. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data.
Johnson DW; Dent H; Yao Q; Tranaeus A; Huang CC; Han DS; Jha V; Wang T; Kawaguchi Y; Qian J
Nephrol Dial Transplant; 2009 May; 24(5):1598-603. PubMed ID: 19096083
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury.
Kim WS; Lee SS; Lee CM; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ; Hong JW; You HS; Cho HC
BMC Infect Dis; 2016 Feb; 16():50. PubMed ID: 26833347
[TBL] [Abstract][Full Text] [Related]
20. Occult hepatitis C virus infection is more common than hepatitis B infection in maintenance hemodialysis patients.
Jain P; Nijhawan S
World J Gastroenterol; 2008 Apr; 14(14):2288-9. PubMed ID: 18407613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
